BRAF and hairy cell leukemia: The BRAF V600E mutation, which is also seen in solid tumors such as melanoma and lung cancer, has since been shown to be present in the vast majority of cases of HCL and constitutes an activating mutation which translates into increased proliferation and survival of malignant cells.